Varespladib methyl has been investigated for the treatment of Acute Coronary Syndrome. Studies showed that Varespladib methyl treatment resulted in significant positive changes on lipoproteins and inflammation.
Investigated for use/treatment in atherosclerosis and coronary artery disease.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.